Stephanie G. Willis

2.5k citations

32 papers · 1.8k indexed · h-index 18

Co-authors: Michael W. Deininger Brian Druker Thomas O’Hare Christopher A. Eide Richard Devereux Kara Johnson Heather A. Bradeen Francis Y. Lee
Topics: Chronic Myeloid Leukemia Treatments (18 papers)Chronic Lymphocytic Leukemia Research (16 papers)Eosinophilic Disorders and Syndromes (10 papers)
Cited by: Hematology Genetics Rheumatology
Journals: Proceedings of the National Academy of SciencesSHILAP Revista de lepidopterologíaBlood
Partner nations: United States Germany Austria

In The Last Decade

Stephanie G. Willis

32 papers receiving 1.7k citations

Peers

Countries citing papers authored by Stephanie G. Willis

Since Specialization

Citations

This map shows the geographic impact of Stephanie G. Willis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephanie G. Willis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephanie G. Willis more than expected).

Fields of papers citing papers by Stephanie G. Willis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephanie G. Willis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephanie G. Willis. The network helps show where Stephanie G. Willis may publish in the future.

Co-authorship network of co-authors of Stephanie G. Willis

This figure shows the co-authorship network connecting the top 25 collaborators of Stephanie G. Willis. A scholar is included among the top collaborators of Stephanie G. Willis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephanie G. Willis. Stephanie G. Willis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Characterization of antibiotic overuse for common infectious disease states at hospital discharge 2023 ·SHILAP Revista de lepidopterología ·(unknown),Andrew Olson,Stephanie G. Willis,Dennis Grauer,(unknown)	2
2	Mutationally Activated TYK2 From T-ALL Specimens Exhibits Tranformative Capacity in Cell Lines and Primary Cell Models and T-Lineage Expansion in Mice 2011 ·Blood ·Angela G. Fleischman,Takaomi Sanda,Alejandro Gutiérrez,Samuel B. Luty,Stephanie G. Willis,A. Thomas Look,Brian Druker,Jeffrey Tyner	2
3	BCR-ABL SH3-SH2 domain mutations in chronic myeloid leukemia patients on imatinib 2010 ·Blood ·Daniel W. Sherbenou,Oliver Hantschel,Ines Kaupe,Stephanie G. Willis,Thomas G.P. Bumm,(unknown),Thoralf Lange,Kim-Hien T. Dao,Richard D. Press,Brian Druker,Giulio Superti‐Furga,Michael W. Deininger	63
4	Mutational Analysis of BCR-Abl From Subjects with Relapsed Ph+ALL Treated On the COG Protocol AALL0031: a Report From the Children's Oncology Group. 2009 ·Blood ·Bill H. Chang,Stephanie G. Willis,Linda C. Stork,Stephen P. Hunger,William L. Carroll,Bruce M. Camitta,Naomi Winick,Brian Druker,Kirk R. Schultz	1
5	RAPID siRNA Screen for Identification of Therapeutic Gene Targets in Patients with Hematologic Malignancies. 2009 ·Blood ·Jeffrey Tyner,Marc Loriaux,Stephanie G. Willis,Bill H. Chang,Vincent T. Bicocca,Stephen T. Oh,Iris H.I.M. Hollink,(unknown),(unknown),Marry M. van den Heuvel‐Eibrink,C. Michel Zwaan,Jason Gotlib,Michael W. Deininger,Brian Druker	2
6	Characterization of BCR-ABL deletion mutants from patients with chronic myeloid leukemia 2008 ·Leukemia ·Daniel W. Sherbenou,Oliver Hantschel,(unknown),Ines Kaupe,Stephanie G. Willis,Thomas G.P. Bumm,Richard D. Press,Giulio Superti‐Furga,Brian Druker,Michael W. Deininger	31
7	Absence of SKP2 expression attenuates BCR-ABL–induced myeloproliferative disease 2008 ·Blood ·Anupriya Agarwal,Thomas G.P. Bumm,Amie S. Corbin,Thomas O’Hare,Marc Loriaux,(unknown),Stephanie G. Willis,Jutta Deininger,Keiichi I. Nakayama,Brian Druker,Michael W. Deininger	54
8	Determining the Rise in BCR-ABL RNA That Optimally Predicts a Kinase Domain Mutation in Patients with CML on Imatinib. 2008 ·Blood ·Richard D. Press,Stephanie G. Willis,Jennifer Laudadio,Michael J. Mauro,Michael W. Deininger	1
9	High-throughput sequencing screen reveals novel, transforming RAS mutations in myeloid leukemia patients 2008 ·Blood ·Jeffrey Tyner,Heidi S. Erickson,Michael W. Deininger,Stephanie G. Willis,Christopher A. Eide,Ross L. Levine,Michael C. Heinrich,Norbert Gattermann,D. Gary Gilliland,Brian Druker,Marc Loriaux	104
10	Comparison of imatinib mesylate, dasatinib (BMS-354825), and nilotinib (AMN107) in an N-ethyl-N-nitrosourea (ENU)–based mutagenesis screen: high efficacy of drug combinations 2006 ·Blood ·Heather A. Bradeen,Christopher A. Eide,Thomas O’Hare,Kara Johnson,Stephanie G. Willis,Francis Y. Lee,Brian Druker,Michael W. Deininger	317
11	BCR-ABL Kinase Domain Mutations in Chronic Myeloid Leukemia: Not Quite Enough to Cause Resistance to Imatinib Therapy? 2005 ·Cell Cycle ·Thoralf Lange,Byung Park,Stephanie G. Willis,Michael W. Deininger	23
12	A single nucleotide polymorphism in the coding region of ABL and its effects on sensitivity to imatinib 2005 ·Leukemia ·Lucy C. Crossman,Thomas O’Hare,Thoralf Lange,Stephanie G. Willis,Eric P. Stoffregen,A. Corbin,S G O'Brien,Michael C. Heinrich,Brian Druker,Peter G. Middleton,Michael W. Deininger	15
13	Detection of ABL kinase domain mutations with denaturing high-performance liquid chromatography 2004 ·Leukemia ·Michael W. Deininger,Laura McGreevey,Stephanie G. Willis,Troy Bainbridge,Brian Druker,Michael C. Heinrich	57
14	Catalytic domains of tyrosine kinases determine the phosphorylation sites within c‐Cbl 2004 ·FEBS Letters ·Arndt Großmann,Kathryn S. Kolibaba,Stephanie G. Willis,A. Corbin,(unknown),Michael W. Deininger,Brian Druker	13
15	In vitro efficacy of combined treatment depends on the underlying mechanism of resistance in imatinib-resistant Bcr-Abl–positive cell lines 2003 ·Blood ·Paul La Rosée,Kara Johnson,Amie S. Corbin,Eric P. Stoffregen,Erika M. Mosesón,Stephanie G. Willis,(unknown),Junia V. Melo,Michael W. Deininger,Brian Druker	82
16	Molecular Phylogenetic and Biogeochemical Studies of Sulfate-Reducing Bacteria in the Rhizosphere of Spartina alterniflora 1999 ·Applied and Environmental Microbiology ·Mark E. Hines,Robert S. Evans,Barbara R. Sharak Genthner,Stephanie G. Willis,Stephanie D. Friedman,Juliette N. Rooney‐Varga,Richard Devereux	130
17	Phenotypic and Genotypic Heterogeneity among Cultivable Pathogen-Related Oral Spirochetes and Treponema vincentii 1999 ·Journal of Clinical Microbiology ·George R. Riviere,Kathryn S. Smith,Stephanie G. Willis,(unknown)	12
18	Phylogenetic and Physiological Diversity of Sulphate-Reducing Bacteria Isolated from a Salt Marsh Sediment 1998 ·Systematic and Applied Microbiology ·Juliette N. Rooney‐Varga,Barbara R. Sharak Genthner,Richard B. Devereux,Stephanie G. Willis,Stephanie D. Friedman,Mark E. Hines	36
19	Genome Sizes of Desulfovibrio desulfuricans , Desulfovibrio vulgaris , and Desulfobulbus propionicus Estimated by Pulsed-Field Gel Electrophoresis of Linearized Chromosomal DNA 1997 ·Current Microbiology ·Richard Devereux,Stephanie G. Willis,Mark E. Hines	9
20	Phylogenetic and physiological comparisons of PAH-degrading bacteria from geographically diverse soils 1997 ·Antonie van Leeuwenhoek ·James G. Mueller,Richard Devereux,Deborah L. Santavy,Suzanne E. Lantz,Stephanie G. Willis,P. H. Pritchard	156

About Stephanie G. Willis

Stephanie G. Willis is a scholar working on Hematology, Genetics and Rheumatology, having authored 32 papers that have together received 1.8k indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (18 papers), Chronic Lymphocytic Leukemia Research (16 papers) and Eosinophilic Disorders and Syndromes (10 papers). The work is most often cited by research in Hematology (1.1k citations), Genetics (871 citations) and Rheumatology (593 citations). Stephanie G. Willis has collaborated with scholars based in United States, Germany and Austria. Frequent co-authors include Michael W. Deininger, Brian Druker, Thomas O’Hare, Christopher A. Eide, Richard Devereux, Kara Johnson, Heather A. Bradeen, Francis Y. Lee, Thoralf Lange and Michael C. Heinrich. Their work appears in journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact